192 related articles for article (PubMed ID: 8685948)
1. The correlation of Banff scoring with reversibility of first and recurrent rejection episodes.
Gaber LW; Schroeder TJ; Moore LW; Shakouh-Amiri MH; Gaber AO
Transplantation; 1996 Jun; 61(12):1711-5. PubMed ID: 8685948
[TBL] [Abstract][Full Text] [Related]
2. Correlation between Banff classification, acute renal rejection scores and reversal of rejection.
Gaber LW; Moore LW; Alloway RR; Flax SD; Shokouh-Amiri MH; Schroder T; Gaber AO
Kidney Int; 1996 Feb; 49(2):481-7. PubMed ID: 8821833
[TBL] [Abstract][Full Text] [Related]
3. Predictors of renal transplant histology at three months.
Kuypers DR; Chapman JR; O'Connell PJ; Allen RD; Nankivell BJ
Transplantation; 1999 May; 67(9):1222-30. PubMed ID: 10342313
[TBL] [Abstract][Full Text] [Related]
4. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria.
Morrissey PE; Gohh R; Shaffer D; Crosson A; Madras PN; Sahyoun AI; Monaco AP
Transplantation; 1997 Mar; 63(6):845-8. PubMed ID: 9089224
[TBL] [Abstract][Full Text] [Related]
5. Tacrolimus therapy for refractory acute renal allograft rejection: definition of the histologic response by protocol biopsies.
Woodle ES; Cronin D; Newell KA; Millis JM; Bruce DS; Piper JB; Haas M; Josephson MA; Thistlethwaite JR
Transplantation; 1996 Oct; 62(7):906-10. PubMed ID: 8878382
[TBL] [Abstract][Full Text] [Related]
6. A Banff Component Scoring-based Histologic Assessment of Bortezomib-based Antibody-mediated Rejection Therapy.
Sadaka B; Ejaz NS; Shields AR; Cardi MA; Wadih G; Witte D; Abu Jawdeh BG; Alloway RR; Woodle ES
Transplantation; 2015 Aug; 99(8):1691-9. PubMed ID: 25803498
[TBL] [Abstract][Full Text] [Related]
7. An evaluation of the Banff classification of early renal allograft biopsies and correlation with outcome.
Bates WD; Davies DR; Welsh K; Gray DW; Fuggle SV; Morris PJ
Nephrol Dial Transplant; 1999 Oct; 14(10):2364-9. PubMed ID: 10528659
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of the rate of progression of chronic renal transplant rejection using the proliferating cell nuclear antigen ].
Simić-Ogrizović S; Starcević-Bozović A; Blagojević R; Radivojević D; Djkanović L
Srp Arh Celok Lek; 2002; 130(5-6):159-64. PubMed ID: 12395435
[TBL] [Abstract][Full Text] [Related]
9. Plasma cell-rich acute renal allograft rejection.
Charney DA; Nadasdy T; Lo AW; Racusen LC
Transplantation; 1999 Sep; 68(6):791-7. PubMed ID: 10515379
[TBL] [Abstract][Full Text] [Related]
10. Acute Antibody-Mediated Rejection in Kidney Transplant Based on the 2013 Banff Criteria: Single-Center Experience in Uruguay.
Nin M; Coitiño R; Kurdian M; Orihuela L; Astesiano R; Garau M; López D; Rievas G; Rodriguez I; González-Martínez F; Noboa O
Transplant Proc; 2016 Mar; 48(2):612-5. PubMed ID: 27110014
[TBL] [Abstract][Full Text] [Related]
11. A blinded retrospective analysis of renal allograft pathology using the Banff schema: implications for clinical management.
Dean DE; Kamath S; Peddi VR; Schroeder TJ; First MR; Cavallo T
Transplantation; 1999 Sep; 68(5):642-5. PubMed ID: 10507482
[TBL] [Abstract][Full Text] [Related]
12. Role of protocol biopsy in early graft dysfunction in renal transplant recipient.
Islam SF; Hadiuzzaman KM; Islam MN; Khanam A; Faroque MO; Ahmed AH
Mymensingh Med J; 2014 Apr; 23(2):286-9. PubMed ID: 24858156
[TBL] [Abstract][Full Text] [Related]
13. Banff criteria as predictors of outcome following acute renal allograft rejection.
Macdonald FI; Ashraf S; Picton M; Dyer PA; Parrott NR; Short CD; Roberts IS
Nephrol Dial Transplant; 1999 Jul; 14(7):1692-7. PubMed ID: 10435878
[TBL] [Abstract][Full Text] [Related]
14. Utility of standardized histological classification in the management of acute rejection. 1995 Efficacy Endpoints Conference.
Gaber LW; Moore LW; Gaber AO; First MR; Guttmann RD; Pouletty P; Schroeder TJ; Soulillou JP
Transplantation; 1998 Feb; 65(3):376-80. PubMed ID: 9484754
[TBL] [Abstract][Full Text] [Related]
15. Immunoexpression of perforin and granzyme B on infiltrating lymphocytes in human renal acute allograft rejection.
Wagrowska-Danilewicz M; Danilewicz M
Nefrologia; 2003; 23(6):538-44. PubMed ID: 15002789
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and predictive value of an immunohistochemical profile in asymptomatic acute rejection of renal allografts.
Copin MC; Noel C; Hazzan M; Janin A; Pruvot FR; Dessaint JP; Lelievre G; Gosselin B
Transpl Immunol; 1995 Sep; 3(3):229-39. PubMed ID: 8581411
[TBL] [Abstract][Full Text] [Related]
17. New scoring system identifies kidney outcome with radiation therapy in acute renal allograft rejection.
Chen LM; Godinez J; Thisted RA; Woodle ES; Thistlewaite JR; Powers C; Haraf D
Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):999-1003. PubMed ID: 10705023
[TBL] [Abstract][Full Text] [Related]
18. The severity of acute cellular rejection defined by Banff classification is associated with kidney allograft outcomes.
Wu K; Budde K; Lu H; Schmidt D; Liefeldt L; Glander P; Neumayer HH; Rudolph B
Transplantation; 2014 Jun; 97(11):1146-54. PubMed ID: 24892962
[TBL] [Abstract][Full Text] [Related]
19. Corticosteroid avoidance in adult kidney transplant recipients under rabbit anti-T-lymphocyte globulin, mycophenolate mofetil and delayed cyclosporine microemulsion introduction.
Cantarovich D; Rostaing L; Kamar N; Saint-Hillier Y; Ducloux D; Mourad G; Garrigue V; Wolf P; Ellero B; Cassuto E; Albano L; Soulillou JP;
Transpl Int; 2010 Mar; 23(3):313-24. PubMed ID: 19843296
[TBL] [Abstract][Full Text] [Related]
20. Serum level of soluble fibrinogen-like protein 2 in renal allograft recipients with acute rejection: a preliminary study.
Zhao Z; Yang C; Tang Q; Zhao T; Jia Y; Ma Z; Rong R; Xu M; Zhu T
Transplant Proc; 2012 Dec; 44(10):2982-5. PubMed ID: 23195010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
